CClinicalTrials.gg
CompletedNCT028188553DMUCOUpdated Feb 5, 2018

Treatment of Multiple Gingival Recessions

A Phase 4 interventional study of Coronally advanced flap (CAF) and Collagen Matrix in Gingival Recession, sponsored by University of Sao Paulo. Completed at 1 site in Brazil. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-02-05.

Sponsored by University of Sao Paulo · Phase 4, Interventional, and Treatment

Phase
Phase 4
Study type
Interventional
Enrollment
15
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Gingival recession (GR) is frequently associated with deterioration in dental esthetics and dental hypersensitivity. Outcomes from recent systematic reviews have demonstrated that when the root is covered and the gain in the width of keratinized tissue (KT) is expected, the use of subepithelial connective tissue grafts (SCTGs) associated with coronally advanced flaps (CAF) appears to be more predictable, and may be considered the gold standard procedure. However, the SCTGs may increase patients' morbidity (e.g., pain). This occurs because of the need for a donor surgical area, which may increase the risk of surgical complications like bleeding, as well as increases post-operative discomfort and the period of the surgical procedure. Another biomaterial, a new collagen matrix (CM) has been used as a substitute for the SCTG. The use of CM was associated with a significant reduction in post-operative morbidity, less post-operative pain and discomfort in the patient, and more esthetic satisfaction.

02

Conditions studied

  • Gingival Recession

Browse trials for

Keywords

  • Root coverage
  • Gingival recession
  • Plastic surgery
  • Connective tissue graft
  • Mucograft
03

In context

Gingival Recession

402 studies on the registry are indexed under Gingival Recession; 98 are open to participants now.

This study's enrollment of 15 is below the median of 30 across 368 interventional studies indexed under Gingival Recession.

Browse Gingival Recession studies →

Lead sponsor

University of Sao Paulo is the lead sponsor of 1,005 studies on the registry; 90 are open to participants now.

Of its 7 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria:

  • The patients will be included in the study if they fulfill the following inclusion criteria:

    1. a clinical diagnosis of multiple-recession type defects at maxillary canines and premolars with at least one GR ≥ 3mm in depth;
    2. areas of Miller's Class I or II GR;
    3. teeth without root abrasions or caries.

Exclusion Criteria: -

The exclusion criteria used will be as follows:

  • patients allergic to collagen
  • a history of smoking (within the previous 6 months)
  • pregnancy or lactation
  • a history of destructive periodontal disease or the formation of recurrent abscesses
  • root caries at the site of recession
  • previous surgical root coverage procedures
  • systemic healing disorders (for example, acquired immunodeficiency syndrome [AIDS], diabetes mellitus or risk factors evaluated by a medical doctor)
  • periodontal disease, or poor plaque control (full mouth plaque index > 20%).

The exclusion criteria for teeth will be:

  1. noncarious cervical lesions (erosion, abfraction etc.)
  2. any type of previous cervical restoration
  3. extrusion
  4. giroversion
  5. mobility
  6. a prominent root surface.
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Single group
Masking
Double (Investigator, Outcomes assessor)
Enrollment
15 participants (actual)

Study arms

  • Experimental
    Collagen Matrix plus coronally advanced flap (CAF)

    A new collagen matrix (Mucograft) associated to coronally advanced flap

    Procedure: Coronally advanced flap (CAF) · Drug: Collagen Matrix

  • Active comparator
    Subepithelial connective tissue graft plus CAF

    Subepithelial connective tissue graft associated to coronally advanced flap

    Procedure: Coronally advanced flap (CAF) · Procedure: Subepithelial connective tissue graft

Interventions

  • ProcedureCoronally advanced flap (CAF)

    The test group will be treated by means of the association of Collagen Matrix + Coronally Advanced Flap. As treatment, the control group will receive the association of a subepithelial Conjunctive Tissue Graft + Coronally Advanced Flap. The aim of both procedures will be to obtain root coverage. All these procedures will be performed in a standardized manner.

    Also known as: Subepithelial conjunctive tissue grafts, Coronally advanced flaps, Coronally advanced flaps associated with collagen matrix

  • DrugCollagen Matrix

    A new collagen membrane

    Also known as: Mucograft

  • ProcedureSubepithelial connective tissue graft

    Connective tissue graft

    Also known as: connective tissue graft

06

What researchers measure

Primary outcomes

  1. Percentage of root coverage (RC)

    The primary clinical outcome will be percentage of root coverage (RC) at 12 months

    Time frame: 12-months

Secondary outcomes

  1. Reductions in recession depth (RRD)

    Measured from the cementum-enamel junction (CEJ) up to the highest point of the gingival margin

    Time frame: At the baseline, 3-month, 6-month and 12-months

  2. Complete root coverage of the gingival recessions (CRC)

    Time frame: At the baseline, 3-month, 6-month and 12-months

  3. Recession width (RW) at the cemento-enamel junction

    Time frame: At the baseline, 3-month, 6-month and 12-months

  4. Relative clinical attachment level (RCAL)

    Measured from a fixed point (stent) prepared on the acrylic guide up to the base of the gingival sulcus.

    Time frame: At the baseline, 3-month, 6-month and 12-months

  5. Probing depth (PD)

    Calculated as RCAL- PD;

    Time frame: At the baseline, 3-month, 6-month and 12-months

  6. keratinized tissue width (KT)

    From the free gingival margin to the mucogingival junction.

    Time frame: At the baseline, 3-month, 6-month and 12-months

  7. Gain in thickness of gingival tissue (GT)

    With an injection needle and a silicon marker, 2mm below the gingival margin.

    Time frame: At the baseline, 3-month, 6-month and 12-months

Other outcomes

  1. Subject esthetic satisfaction by participants

    The participants will be invited to reply to a questionnaire on subject esthetic satisfaction with the surgical results (from dissatisfied to very satisfied) on a scale of 1-5, as well as after 1, 3, 6 months and after 12 months.

    Time frame: 1, 3, 6 months and after 12 months

  2. Subjective symptoms of pain and discomfort by participants

    Subjective symptoms of pain and discomfort (without pain and with a great deal of pain) will be evaluated with 10 cm (0-10) visual analog scales (VAS) at 1, 2, 3-week, 1 month, 3-month, 6-month and12-months.

    Time frame: At 1, 2, 3-week, 1 month, 3-month, 6-month and12-months.

  3. Esthetic questionnaire by experienced periodontist

    One experienced periodontist will be invited to observe the initial photographs and those of the clinical results obtained during the entire healing process and asked to respond to an esthetic questionnaire (from dissatisfied to very satisfied) on a scale of 1 to 5 points after 1, 2, 3-week, 1-month, 3-month, 6-month and 12-months.12 All this examinations also will be performed in the clinic.

    Time frame: 1, 2, 3-week, 1-month, 3-month, 6-month and 12-months after surgery

07

Study locations

1 site
  • University of São Paulo
    São Paulo, 05508-000, Brazil
08

References and documents

Publications

  • Jepsen K, Jepsen S, Zucchelli G, Stefanini M, de Sanctis M, Baldini N, Greven B, Heinz B, Wennstrom J, Cassel B, Vignoletti F, Sanz M. Treatment of gingival recession defects with a coronally advanced flap and a xenogeneic collagen matrix: a multicenter randomized clinical trial. J Clin Periodontol. 2013 Jan;40(1):82-9. doi: 10.1111/jcpe.12019. Epub 2012 Oct 10. PubMed 23050490 ↗
  • McGuire MK, Scheyer ET. Xenogeneic collagen matrix with coronally advanced flap compared to connective tissue with coronally advanced flap for the treatment of dehiscence-type recession defects. J Periodontol. 2010 Aug;81(8):1108-17. doi: 10.1902/jop.2010.090698. PubMed 20350159 ↗
  • Sanz M, Lorenzo R, Aranda JJ, Martin C, Orsini M. Clinical evaluation of a new collagen matrix (Mucograft prototype) to enhance the width of keratinized tissue in patients with fixed prosthetic restorations: a randomized prospective clinical trial. J Clin Periodontol. 2009 Oct;36(10):868-76. doi: 10.1111/j.1600-051X.2009.01460.x. Epub 2009 Aug 12. PubMed 19678861 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 5, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02818855
Lead sponsor
University of Sao Paulo
Responsible party
Giuseppe Alexandre Romito (Chairperson, Department of Periodontics, University of Sao Paulo) — Principal investigator
First posted
Jun 30, 2016
Start date
Mar 2014
Primary completion
Oct 2015
Completion
Apr 2016
Last update
Feb 5, 2018

Study contacts

Giuseppe Romito, PhD
study chair · University of Sao Paulo

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion